SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-015537
Filing Date
2020-04-06
Accepted
2020-04-06 16:52:22
Documents
5
Period of Report
2020-05-20
Effectiveness Date
2020-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A vir-def14a_20200520.htm DEF 14A 889886
2 GRAPHIC g2wgzmhosj5y000004.jpg GRAPHIC 55090
3 GRAPHIC g2wgzmhosj5y000002.jpg GRAPHIC 3332
4 GRAPHIC g2wgzmhosj5y000001.jpg GRAPHIC 3332
5 GRAPHIC g2wgzmhosj5y000003.jpg GRAPHIC 46521
  Complete submission text file 0001564590-20-015537.txt   1040647
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39083 | Film No.: 20777544
SIC: 2836 Biological Products, (No Diagnostic Substances)